摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(1-萘乙酰基)氨基]乙酸 | 6277-60-7

中文名称
(1-萘乙酰基)氨基]乙酸
中文别名
——
英文名称
(2-naphthalen-1-ylacetylamino)acetic acid
英文别名
Naphthyl-acetylglycin;N-[1]naphthylacetyl-glycine;N-[1]Naphthylacetyl-glycin;N-α-Naphthylacetyl-glycine;[(1-Naphthylacetyl)amino]acetic acid;2-[(2-naphthalen-1-ylacetyl)amino]acetic acid
(1-萘乙酰基)氨基]乙酸化学式
CAS
6277-60-7
化学式
C14H13NO3
mdl
MFCD04627342
分子量
243.262
InChiKey
BMZHJBUIQBHUPO-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2
  • 重原子数:
    18
  • 可旋转键数:
    4
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.142
  • 拓扑面积:
    66.4
  • 氢给体数:
    2
  • 氢受体数:
    3

安全信息

  • 海关编码:
    2924299090

SDS

SDS:33fcbd728283acd297eaee302f08ca25
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    (1-萘乙酰基)氨基]乙酸3-(二甲氨基)吡咯烷N,N-二异丙基乙胺N,N'-二环己基碳二亚胺 作用下, 以 二氯甲烷 为溶剂, 以62%的产率得到N-[2-(3-dimethylaminopyrrolidin-1-yl)-2-oxoethyl]-2-naphthalen-1-ylacetamide
    参考文献:
    名称:
    Protection of Primary Dopaminergic Midbrain Neurons by GPR139 Agonists Supports Different Mechanisms of MPP+ and Rotenone Toxicity
    摘要:
    The G-protein coupled receptor 139 (GPR139) is expressed specifically in the brain in areas of relevance for motor control. GPR139 function and signal transduction pathways are elusive, and results in the literature are even contradictory. Here, we examined the potential neuroprotective effect of GPR139 agonism in primary culture models of dopaminergic (DA) neuronal degeneration. We find that in vitro GPR139 agonists protected primary mesencephalic DA neurons against 1-methyl-4-phenylpyridinium (MPP)-mediateddegeneration. Protection was concentration-dependent and could be blocked by a GPR139 antagonist. However, the protection of DA neurons was not found against rotenone or 6-hydroxydopamine (6-0HDA) mediated degeneration. Our results support differential mechanisms of toxicity for those substances commonly used in Parkinson's disease (PD) models and potential for GPR139 agonists in neuroprotection.
    DOI:
    10.3389/fncel.2016.00164
  • 作为产物:
    描述:
    1-萘乙酸盐酸-N-乙基-Nˊ-(3-二甲氨基丙基)碳二亚胺三乙胺 、 sodium hydroxide 作用下, 以 乙醇二氯甲烷 为溶剂, 反应 34.0h, 生成 (1-萘乙酰基)氨基]乙酸
    参考文献:
    名称:
    Protection of Primary Dopaminergic Midbrain Neurons by GPR139 Agonists Supports Different Mechanisms of MPP+ and Rotenone Toxicity
    摘要:
    The G-protein coupled receptor 139 (GPR139) is expressed specifically in the brain in areas of relevance for motor control. GPR139 function and signal transduction pathways are elusive, and results in the literature are even contradictory. Here, we examined the potential neuroprotective effect of GPR139 agonism in primary culture models of dopaminergic (DA) neuronal degeneration. We find that in vitro GPR139 agonists protected primary mesencephalic DA neurons against 1-methyl-4-phenylpyridinium (MPP)-mediateddegeneration. Protection was concentration-dependent and could be blocked by a GPR139 antagonist. However, the protection of DA neurons was not found against rotenone or 6-hydroxydopamine (6-0HDA) mediated degeneration. Our results support differential mechanisms of toxicity for those substances commonly used in Parkinson's disease (PD) models and potential for GPR139 agonists in neuroprotection.
    DOI:
    10.3389/fncel.2016.00164
点击查看最新优质反应信息

文献信息

  • Discovery of diaminobutane derivatives as Ca 2+ -permeable AMPA receptor antagonists
    作者:Yoshiyuki Yoneda、Tetuya Mimura、Keiichi Kawagoe、Takanori Yasukouchi、Toshiaki Tatematu、Masayuki Ito、Masaki Saito、Masunobu Sugimura、Fusako Kito、Shinichi Kawajiri
    DOI:10.1016/s0968-0896(01)00398-4
    日期:2002.5
    the course of this study, we found that the polyamine derivatives exhibited strong hypotensive activity which was undesirable activity for neuroprotective agents. Therefore, we tried to find non-hypotensive antagonists by structural modification of such compounds. Through this derivatization, we obtained the diamine compounds having desired profiles. Especially, compound 8f, which was non-hypotensive
    我们设计和合成了一系列的多胺衍生物作为有效的Ca(2+)渗透性AMPA受体拮抗剂。在研究过程中,我们发现多胺衍生物表现出很强的降压活性,这对于神经保护剂是不希望的。因此,我们试图通过对这类化合物进行结构修饰来找到非降压拮抗剂。通过这种衍生作用,我们获得了具有所需特性的二胺化合物。特别是,化合物8f,它是非降压和有效的Ca(2+)渗透性AMPA受体拮抗剂,在沙鼠的短暂性全球缺血模型中显示出神经保护作用。
  • Overcoming Energy Transfer for the Metallophotoredox Catalyzed Decarboxylative Alkenylation between Alkylcarboxylic Acids and Enol Triflates
    作者:Stephan Korsgaard Pedersen、Sebastian Clementson、Jesper Langgaard Kristensen、Mikkel Jessing、Kassem El-Chami
    DOI:10.1002/chem.202300265
    日期:——
    Overcoming Energy Transfer for the metallophotoredox catalyzed decarboxylative alkenylation between alkylcarboxylic acids and enol triflates.
    克服金属光氧化还原催化的烷基羧酸和烯醇三氟甲磺酸酯之间的脱羧烯基化的能量转移。
  • Synthesis of polyamine derivatives Having non-hypotensive Ca2+-permeable AMPA receptor antagonist activity
    作者:Yoshiyuki Yoneda、Shinichi Kawajiri、Atushi Hasegawa、Fusako Kito、Sumie Katano、Emi Takano、Tetuya Mimura
    DOI:10.1016/s0960-894x(01)00170-6
    日期:2001.5
    In order to obtain non-hypotensive and Ca2+-permeable AMPA receptor antagonists, we have synthesized a series of 1,4-bis(4-piperidinylmethyl)diaminobutanes. Compounds 13b, c, f had desirable properties. (C) 2001 Elsevier Science Ltd. All rights reserved.
  • alpha-naphthacetyl-amino acids and process for the manufacture of same
    申请人:HOFFMANN LA ROCHE
    公开号:US02179979A1
    公开(公告)日:1939-11-14
  • DE714184
    申请人:——
    公开号:——
    公开(公告)日:——
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物